Increased expression of IL-16 in inflammatory bowel disease
- 1 March 2001
- Vol. 48 (3) , 326-332
- https://doi.org/10.1136/gut.48.3.326
Abstract
BACKGROUND AND AIMS The choice of colorectal surgery in patients with familial adenomatous polyposis lies between the morbidity of proctocolectomy and ileum-pouch-anal anastomosis (IPAA) and the mortality from rectal cancer after total colectomy and ileorectal anastomosis (IRA). The aims of the present study were: (1) to assess the risk of dying from rectal cancer after IRA, (2) to compare the life expectancy between patients with an IRA and those with an IPAA, and (3) to investigate whether regular endoscopic examination of the rectum leads to detection of cancer at an earlier stage. METHODS Clinical and pathological data on 659 patients who underwent colectomy and ileorectal anastomosis were collected from four national polyposis registries—that is, in Denmark, Finland, Sweden, and the Netherlands. Data were analysed using survival analysis methods. Decision analysis was used to compare the life expectancy between patients with an IRA and those with an IPAA. RESULTS A total of 47 patients developed rectal cancer after IRA. The risk of dying from rectal cancer was 12.5% (95% confidence interval 7.1–17.9%) by age 65. Compared with IRA, IPAA would lead to an increase in life expectancy of 1.8 years. Seventy five per cent of patients with rectal cancer had a negative rectoscopy within 12 months before the diagnosis. CONCLUSION IRA is associated with substantial mortality due to rectal cancer. Follow up examinations of the rectum does not have sufficient preventive effect on morbidity and mortality of rectal cancer.Keywords
This publication has 34 references indexed in Scilit:
- Interleukin‐16 stimulates the expression and production of pro‐inflammatory cytokines by human monocytesImmunology, 2000
- Processing and Activation of Pro-Interleukin-16 by Caspase-3Journal of Biological Chemistry, 1998
- Signaling and Functional Properties of lnterleukin-16International Reviews of Immunology, 1998
- Increased Expression of Interleukin-16 in Bronchial Mucosa of Subjects with Atopic AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependentDigestive Diseases and Sciences, 1995
- Bronchial epithelial cells of patients with asthma release chemoattractant factors for T lymphocytesJournal of Allergy and Clinical Immunology, 1993
- Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestineClinical and Experimental Immunology, 1990
- Role of interleukin 1 in inflammatory bowel disease--enhanced production during active disease.Gut, 1990
- Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.BMJ, 1989
- Chemoattractant lymphokines specific for the helper/inducer T-lymphocyte subsetCellular Immunology, 1985